Dry Powder: The Private Equity Podcast
The Case for “Guarded Optimism” in the Healthcare Sector
It’s shaping up to be a surprisingly robust year for private equity deal activity in the healthcare sector.
- agosto 29, 2024
One recurring question we’ve been asking on Dry Powder is when the private equity industry will finally regain its momentum. Today on the podcast, we may have a clue.
You can listen to this episode of Dry Powder and catch future episodes by subscribing on Apple Podcasts, Google Podcasts, Spotify, or wherever you may listen.
“As we pulled together the deal trends for our midyear report,” says Kara Murphy, coleader of Bain’s Global Healthcare Private Equity group, “healthcare PE is having one of its top three to five years ever.”
While she cautions that healthcare deals are still off from their 2021 highs, there’s a case to be made for optimism. Nirad Jain, who coleads the Global Healthcare Private Equity group, sees pockets of deal activity everywhere.
“Even in the month of August, we saw Carlyle announce the large Vantive carve-out from Baxter for almost $4 billion,” Nirad says, “and I think these are very important markers for the broader market to have confidence that dealmaking is getting back to a new normal.”
Today on the show, I ask Kara and Nirad whether 2024 could mark the beginning of a broad-based recovery for the healthcare sector and what that means for an industry in search of momentum.
The Private Equity Podcast
In our podcast series, Bain's Hugh MacArthur interviews leading experts on the trends and opportunities that will redefine the private equity industry.